Xencor Inc
NASDAQ:XNCR
Xencor Inc
NASDAQ:XNCR
Price:
12.25
USD
-0.49%
Market Closed
Market Cap:
$898.4m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Xencor Inc
NASDAQ:XNCR
|
US |
|
HCR Co Ltd
SSE:688500
|
CN |
|
Delorean Corporation Ltd
ASX:DEL
|
AU |
|
C
|
Consolidated Construction Consortium Ltd
NSE:CCCL
|
IN |
|
Cebu Air Inc
OTC:CEBUY
|
PH |
|
L'Oreal SA
PAR:OR
|
FR |
|
J
|
JTF International Holdings Ltd
HKEX:8479
|
CN |
|
Schweiter Technologies AG
SIX:SWTQ
|
CH |
|
Hallenstein Glasson Holdings Ltd
NZX:HLG
|
NZ |
|
Bankinter SA
MAD:BKT
|
ES |
|
Fox Marble Holdings PLC
LSE:FOX
|
UK |
|
D
|
Despec Bilgisayar Pazarlama ve Ticaret AS
IST:DESPC.E
|
TR |
Multiples-Based Value
The Multiples-Based Value of one
XNCR
stock under the Base Case scenario is
hidden
USD.
Compared to the current market price of 12.25 USD,
Xencor Inc
is
hidden
.
Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
XNCR Multiples-Based Value
LOCKED
Multiples Across Competitors
XNCR Competitors Multiples
Xencor Inc Competitors
Xencor Inc Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| US |
|
Xencor Inc
NASDAQ:XNCR
|
880.4m USD | 7 | -9.6 | -2.5 | -2.3 | |
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD | 33 690 872.8 | -160 127.7 | -194 446.1 | -192 227.3 | |
| US |
|
Abbvie Inc
NYSE:ABBV
|
374.1B USD | 6.1 | 89.4 | 14.8 | 20.5 | |
| US |
|
Amgen Inc
NASDAQ:AMGN
|
188.5B USD | 5.1 | 24.4 | 14.2 | 14.2 | |
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
175.7B USD | 6 | 20.7 | 12.9 | 15.9 | |
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
112.8B USD | 9.4 | 28.5 | 21.4 | 22.4 | |
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR | 2 091 | -533.6 | -581 | -565.5 | |
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
82B USD | 5.7 | 18.2 | 13.7 | 15.6 | |
| NL |
|
argenx SE
XBRU:ARGX
|
41.5B EUR | 11.7 | 37.5 | 40.5 | 41.4 | |
| AU |
|
CSL Ltd
ASX:CSL
|
68.5B AUD | 3 | 33.2 | 11.2 | 14 | |
| US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR | 20.1 | -61.8 | -66.6 | -60.1 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
